🇺🇸 METHAMPHETAMINE HYDROCHLORIDE in United States

FDA authorised METHAMPHETAMINE HYDROCHLORIDE on 25 February 2004 · 1,023 US adverse-event reports

Marketing authorisations

FDA — authorised 25 February 2004

  • Application: ANDA040529
  • Marketing authorisation holder: ABLE
  • Local brand name: METHAMPHETAMINE HYDROCHLORIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 21 April 2010

  • Application: ANDA091189
  • Marketing authorisation holder: DR REDDYS LABS SA
  • Local brand name: METHAMPHETAMINE HYDROCHLORIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 17 November 2015

  • Application: ANDA203846
  • Marketing authorisation holder: HIKMA
  • Local brand name: METHAMPHETAMINE HYDROCHLORIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

FDA

  • Application: ANDA086359
  • Marketing authorisation holder: TEVA
  • Local brand name: METHAMPHETAMINE HYDROCHLORIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Toxicity To Various Agents — 265 reports (25.9%)
  2. Drug Abuse — 229 reports (22.39%)
  3. Completed Suicide — 90 reports (8.8%)
  4. Death — 90 reports (8.8%)
  5. Cardiac Arrest — 70 reports (6.84%)
  6. Drug Interaction — 68 reports (6.65%)
  7. Respiratory Arrest — 64 reports (6.26%)
  8. Cardio-Respiratory Arrest — 49 reports (4.79%)
  9. Overdose — 49 reports (4.79%)
  10. Substance Abuse — 49 reports (4.79%)

Source database →

METHAMPHETAMINE HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is METHAMPHETAMINE HYDROCHLORIDE approved in United States?

Yes. FDA authorised it on 25 February 2004; FDA authorised it on 21 April 2010; FDA authorised it on 17 November 2015.

Who is the marketing authorisation holder for METHAMPHETAMINE HYDROCHLORIDE in United States?

ABLE holds the US marketing authorisation.